Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$3.47 - $4.61 $186,686 - $248,018
-53,800 Reduced 12.64%
371,900 $1.53 Million
Q4 2023

Feb 13, 2024

BUY
$3.38 - $4.58 $977,834 - $1.32 Million
289,300 Added 212.1%
425,700 $1.8 Million
Q3 2023

Nov 14, 2023

BUY
$4.28 - $6.57 $583,792 - $896,148
136,400 New
136,400 $589,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $274M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.